<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02932358</url>
  </required_header>
  <id_info>
    <org_study_id>ICU Visits</org_study_id>
    <nct_id>NCT02932358</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety of a Flexible Family Visitation Model in Adult Intensive Care Units: a Cluster-randomized, Crossover Trial (The ICU Visits Study)</brief_title>
  <official_title>Effectiveness and Safety of a Flexible Family Visitation Model in Adult Intensive Care Units: a Cluster-randomized, Crossover Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Moinhos de Vento</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Moinhos de Vento</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cluster-randomized crossover trial involving adult ICU patients, family members, and ICU
      professionals will be conducted. Forty medical-surgical Brazilian ICUs with visiting hours
      &lt;4.5 h/day will be randomly assigned to either a restrictive family visitation model (RFVM)
      (visits according to local policies) or a flexible family visitation model (FFVM) (visitation
      during 12 consecutive hours per day) at a 1:1 ratio. After enrollment and follow-up of 25
      patients, each ICU will be switched over to the other visitation model, until 25 more
      patients per site are enrolled and followed. The primary outcome will be the cumulative
      incidence of delirium among ICU patients, measured twice a day using the Confusion Assessment
      Method for the ICU. Secondary outcome measures will include delirium-free days,
      ventilator-free days, any ICU-acquired infections, ICU length of stay, and all-cause hospital
      mortality among the patients; symptoms of anxiety and depression and satisfaction among the
      family members; and prevalence of symptoms of burnout among the ICU professionals. Tertiary
      outcomes will include need for antipsychotic agents and/or mechanical restraints, unplanned
      loss of invasive devices, and ICU-acquired pneumonia, urinary tract infection, or bloodstream
      infection among the patients; self-perception of involvement in patient care among the family
      members; and satisfaction among the ICU professionals.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The following interventions will be evaluated in the present study: restrictive family visitation model (intermittent visits according to local ICU regulation) and flexible family visitation model (12 consecutive hours per day). The unit of of concealed randomization is the ICU to minimize the risk of contamination, given that we intend to apply the intervention to the whole ICU multidisciplinary team. We will randomize ICUs to either an RFVM or to an FFVM as the initial intervention (T1). After enrollment of 25 ICU patients, there will be a 30-day period without recruitment to avoid contamination bias. After this period, each ICU will be assigned to an intervention contrary to that which initially receive (T2) until the enrollment of more 25 ICU patients.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Delirium among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Incidence of delirium will be verified by trained intensive care physicians and nursers with the confusion assessment method for the ICU 2 times per day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delirium free-days among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Days alive and free of delirium during ICU stay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antipsychotic use among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Rates of antipsychotic use during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of mechanical restraints among ICU patients</measure>
    <time_frame>During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)</time_frame>
    <description>Need of mechanical restraints among ICU patients during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned removal of invasive devices among ICU patients</measure>
    <time_frame>During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)</time_frame>
    <description>Unplanned removal of venous catheter, tube feeding or urinary catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation-free days among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Days alive and free of mechanical ventilation during ICU stay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any ICU-acquired infection among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Pneumonia or bloodstream infection or urinary tract infection acquired after 48 hours of ICU admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-acquired pneumonia among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Pneumonia acquired after 48 hours of ICU admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-acquired bloodstream infection among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Bloodstream infection acquired after 48 hours of ICU admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-acquired urinary tract infection among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Urinary tract infection acquired after 48 hours of ICU admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any ICU-acquired multi-drug resistant infection among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Pneumonia or bloodstream infection or urinary tract infection due to multi-drug resistant bacteria acquired after 48 hours of ICU admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay among ICU patients</measure>
    <time_frame>During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>Length of ICU stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause hospital mortality among ICU patients</measure>
    <time_frame>During hospital stay (from enrollment until hospital discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>rates of all-cause mortality during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of anxiety among ICU visitors</measure>
    <time_frame>It will be measured in two moments during patient ICU stay (within the first 48hs of patient enrollment and on the day of ICU discharge, or death or a maximum of 30 days of follow-up)</time_frame>
    <description>symptoms of anxiety among ICU visitors measured by de Hospital Anxiety and Depression scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of depression among ICU visitors</measure>
    <time_frame>In two moments during patient ICU stay (within the first 48hs of patient enrollment and on the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.</time_frame>
    <description>symptoms of depression among ICU visitors measured by de Hospital Anxiety and Depression scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction among among ICU visitors</measure>
    <time_frame>On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.</time_frame>
    <description>Rates of patient's families satisfaction measured by the critical care family needs inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Burnout Syndrome symptoms among ICU workers</measure>
    <time_frame>It will be measured in two moments: within 15 days prior to the first ICU intervention and between the 15th and 30th days of the period in which no patient will be enrolled.</time_frame>
    <description>Incidence of Burnout Syndrome symptoms among ICU workers measured by the Maslach Burnout Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any adverse event related to ICU visitation</measure>
    <time_frame>During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)</time_frame>
    <description>Any adverse event possible related to the ICU visitation model</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1650</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Flexible Family Visitation Model (FFVM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the FFVM, two or fewer family members will be allowed to visit the patient for up to 12 consecutive hours each day. In addition to family visitation, patients will be allowed to receive social visits in specific time intervals (according local ICU regulation). To have access to the FFVM, family members of ICU patients will have to attend a structured meeting at ICU in which they will receive orientations about the ICU environment, common ICU treatments, rehabilitation and basic infection control practices, multidisciplinary work at ICU and palliative treatment. Social visitors will not be required to attend the structured meeting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restrictive Family Visitation Model (RFVM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the RFVM, patients will be allowed to receive restricted visits according routine ICU practices, but respecting the maximum limit of 4.5 hours of visitation per day. Visitors will not be required to attend the structured meeting. The length of ICU visits will be similar to those of social visits in the FFVM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flexible Family Visitation Model (FFVM)</intervention_name>
    <description>Visitation to ICU patients allowed during the period of 12 consecutive hours per day.</description>
    <arm_group_label>Flexible Family Visitation Model (FFVM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Restrictive Family Visitation Model (RFVM)</intervention_name>
    <description>Visitation to ICU patients allowed during intermittent periods according local ICU regulation.</description>
    <arm_group_label>Restrictive Family Visitation Model (RFVM)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For ICUs: clinical-surgical brazilian ICUs with restricted visitation policies(&lt;4.5
             hours/day).

          -  For Patients: Age ≥ 18 years, admission to the intensive care unit.

          -  For Patient's Family Members: nearest relative of the ICU patient recruited in the
             study and consent to participate in the study.

          -  For ICU Workers: ICU workers that assist patients in the ICU during the daytime for at
             least 20 hours per week and consent to participate in the study.

        Exclusion Criteria:

          -  For ICUs: ICUs with structural or organizational impediments to extended visitation.

          -  For Patients: Subjects with coma (Richmond Agitation Sedation Scale -4 or -5) lasting
             &gt; 96 hours from the moment of first evaluation for recruitment, or delirium at the
             baseline (positive Confusion Assessment Method for ICU) will be excluded. Individuals
             with cerebral death, aphasia, severe hearing deficit, a prediction of ICU length of
             stay &lt; 48 hours, exclusively palliative treatment, or without a familiar member able
             to participate in extended ICU visits and those who are prisioners, unlikely to
             survive &gt;24hs, re-admitted to the ICU after enrolment in the study will also be
             excluded.

          -  For Patient's Family Members: Another ICU patient's relative enrolled in the study;
             family members who don't speak Portuguese; Difficulty to answer the self-administered
             questionnaires (e.g.: illiteracy)

          -  For ICU Workers: ICU workers who have a prediction of withdrawal of ICU care
             activities &gt;15 days during the study will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Regis Rosa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Moinhos de Vento</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Regis G Rosa, MD, PhD</last_name>
    <phone>5551996031358</phone>
    <email>regisgoulartrosa@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de Urgência e Emergência de Rio Branco</name>
      <address>
        <city>Rio Branco</city>
        <state>AC</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Fundação Hospital Adriano Jorge</name>
      <address>
        <city>Manaus</city>
        <state>AM</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliane P Paulo, RN</last_name>
      <email>enfermeira-lili@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Eliane P Paulo, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Geral Clériston Andrade</name>
      <address>
        <city>Feira De Santana</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital INCARDIO</name>
      <address>
        <city>Feira De Santana</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Estadual de Urgência e Emergência de Vitória</name>
      <address>
        <city>Vitória</city>
        <state>ES</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Urgências de Goiânia</name>
      <address>
        <city>Goiânia</city>
        <state>Goias</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital das Clínicas da Universidade Federal de Minas Gerais</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vandack A Nobre Jr, MD</last_name>
      <email>vandack@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vandack A Nobre Jr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericórdia de São João Del Rei</name>
      <address>
        <city>São João Del Rei</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge L Paranhos, MD</last_name>
      <email>jorgeparanhos@uol.com.br</email>
    </contact>
    <investigator>
      <last_name>Jorge L Paranhos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Regional do Baixo Amazonas</name>
      <address>
        <city>Santarém</city>
        <state>PA</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitário Alcides Carneiro</name>
      <address>
        <city>Campina Grande</city>
        <state>PB</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda D Nobre, RN</last_name>
      <email>amandamanuella@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Amanda D Nobre, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitário Lauro Wanderley</name>
      <address>
        <city>João Pessoa</city>
        <state>PB</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucrécia Bezerra, RN</last_name>
      <email>lucreciabezerra@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Lucrécia Bezerra, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitário de Petrolina</name>
      <address>
        <city>Petrolina</city>
        <state>PE</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saulo Xavier, RN</last_name>
      <email>saulo.xavier@ebserh.gov.br</email>
    </contact>
    <investigator>
      <last_name>Kátia R Oliveira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saulo Xavier, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Agamenom Magalhães</name>
      <address>
        <city>Recife</city>
        <state>PE</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcos Gallindo, MD</last_name>
      <email>macgallindo@uol.com.br</email>
    </contact>
    <investigator>
      <last_name>Marcos Gallindo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitário da Universidade Federal do Piauí</name>
      <address>
        <city>Teresina</city>
        <state>PI</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rejane Prestes, MD</last_name>
      <email>prestesrejane@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rejane Prestes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital do Caâncer de Cascavel (UOPECCAN)</name>
      <address>
        <city>Cascavel</city>
        <state>PR</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delmiro Becker, RN</last_name>
      <email>delmiro.becker@uopeccan.org.br</email>
    </contact>
    <investigator>
      <last_name>Péricles Duarte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delmiro Becker, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitário do Oeste do Paraná (UNIOESTE)</name>
      <address>
        <city>Cascavel</city>
        <state>PR</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lizandra Ayres, RN</last_name>
      <email>lizandrayres@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Péricles Duarte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lizandra Ayres, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Geral de Nova Iguaçú</name>
      <address>
        <city>Nova Iguaçú</city>
        <state>RJ</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Sodré, MD</last_name>
      <email>alexandersodre@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Alexander Sodré, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Deoclécio Marques de Lucena</name>
      <address>
        <city>Parnamirim</city>
        <state>RN</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro S Dantas, MD</last_name>
      <email>agaprn@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Alessandro S Dantas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Tacchini</name>
      <address>
        <city>Bento Gonçalves</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital São Camilo de Esteio</name>
      <address>
        <city>Esteio</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina Karnopp, RN</last_name>
      <email>ckarnopp4@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Luciana C Miguel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carolina Karnopp, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital da Cidade de Passo Fundo</name>
      <address>
        <city>Passo Fundo</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janaína Pilau, MD</last_name>
      <email>jpilau@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Janaína Pilau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Dom Vicente Scherer</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Mãe de Deus</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Nossa Senhora da Conceiçaão</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Rita</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital São Lucas da PUCRS</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Pavilhão Pereira Filho</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Ana Nery</name>
      <address>
        <city>Santa Cruz Do Sul</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael B Foernges, MD</last_name>
      <email>rbfoernges@icloud.com</email>
    </contact>
    <investigator>
      <last_name>Rafael Foernges, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clébio Teixeira, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Cruz</name>
      <address>
        <city>Santa Cruz Do Sul</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael B Foernges, MD</last_name>
      <email>rbfoernges@icloud.com</email>
    </contact>
    <investigator>
      <last_name>Rafael Foernges, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andréia S Carvalho, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dona Helena</name>
      <address>
        <city>Joinville</city>
        <state>SC</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto</name>
      <address>
        <city>Ribeirão Preto</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilson Lovato, MD</last_name>
      <email>wjlovato@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Wilson Lovato, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital do Coração (HCor)</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinícius Werneck, MD</last_name>
      <email>vawerneck@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Vinícius Werneck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Alberto Urquiza Wanderley (UNIMED João Pessoa)</name>
      <address>
        <city>João</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Igor M do Nascimento, MD</last_name>
      <email>igormdn80@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Igor M do Nascimento, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Montenegro</name>
      <address>
        <city>Montenegro</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Pettine, MD</last_name>
      <email>zekapettine@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Moreno C dos Santos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Pettine, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2016</study_first_submitted>
  <study_first_submitted_qc>October 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>January 15, 2018</last_update_submitted>
  <last_update_submitted_qc>January 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive care units</keyword>
  <keyword>Delirium</keyword>
  <keyword>Cross infection</keyword>
  <keyword>Mortality</keyword>
  <keyword>Length of stay</keyword>
  <keyword>Burnout, Professional</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

